Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Proposed Acquisition of European Medical Testing Subsidiary (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Amphastar Pharmaceuticals Inc AMPH

Healthcare
Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically challenging generic and injectable, inhalation, and intranasal products. Additionally, it sells insulin API products. Most of its finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed... see more

Recent & Breaking News (NDAQ:AMPH)

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2020

GlobeNewswire May 7, 2020

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2020

GlobeNewswire May 4, 2020

Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial

GlobeNewswire April 27, 2020

Amphastar Pharmaceuticals, Inc. Announces Simplification of Management Structure

GlobeNewswire April 13, 2020

Amphastar Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference

GlobeNewswire April 9, 2020

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2019

GlobeNewswire March 12, 2020

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12th, 2020

GlobeNewswire March 5, 2020

Amphastar Pharmaceuticals Receives FDA Approval for Supplement to its Abbreviated New Drug Application for Sodium Bicarbonate Injection, USP 8.4%, 50mEq/50mL

GlobeNewswire February 27, 2020

Amphastar Announces the Receipt of a MINOR CRL for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial

GlobeNewswire January 28, 2020

Amphastar Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference

GlobeNewswire November 27, 2019

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

GlobeNewswire November 15, 2019

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2019

GlobeNewswire November 7, 2019

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 7th, 2019

GlobeNewswire November 1, 2019

Amphastar Pharmaceuticals to Present at the Wells Fargo 2019 Healthcare Conference

GlobeNewswire August 29, 2019

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2019

GlobeNewswire August 7, 2019

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2019

GlobeNewswire August 5, 2019

Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference

GlobeNewswire June 24, 2019

Amphastar Pharmaceuticals, Inc. Announces Settlement in Litigation with Momenta and Sandoz

GlobeNewswire June 19, 2019

Amphastar Pharmaceuticals to Present at the Raymond James Life Sciences and MedTech Healthcare Conference

GlobeNewswire June 14, 2019

Amphastar Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference

GlobeNewswire May 31, 2019